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LETTER TO THE EDITOR
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[TAVI registries: Full disclosure?
Publication  des  registres  TAVI  :  transparence  ?
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Transcatheter  aortic  valve  implantation  (TAVI)  is  an  increas-
ingly  recognized  modality  for  the  treatment  of  severe  aortic
stenosis.  The  randomized  Placement  of  Aortic  Transcatheter
Valves  (PARTNER)  trial  [1]  followed  by  national  registries
such  as  the  French  Aortic  National  CoreValve  and  Edwards
(FRANCE  2)  Registry  [2]  have  provided  strong  evidence  in
favour  of  TAVI  procedures  in  high-risk  patients  with  severe
aortic  valve  stenosis  with  a  Society  of  Thoracic  Surgeons
(STS)  score  >  10%  or  EuroSCORE  >  20%.  Outcomes  were  similar
in  TAVI  and  surgical  cohorts  in  the  PARTNER  trial  [1].  Of  note,
any  percutaneous  coronary  intervention  (PCI)  within  30  days
of  a  bare-metal  stent  implantation  or  within  6  months  of  a
drug-eluting  stent  implantation  was  an  exclusion  criterion
in  the  PARTNER  trial.  Three-quarters  of  the  patients  in  the
PARTNER  trial  did,  however,  have  coronary  artery  disease
(CAD);  43%  of  the  patients  had  had  coronary  artery  bypass
graft  (CABG)  surgery  and  32%  had  undergone  PCI  [1].  In  the
FRANCE  2  registry,  48%  of  the  3195  patients  had  a  history
of  CAD  and  18%  had  previous  CABG  surgery  [2].  Similarly,  in
the  Belgian  national  registry  58%  of  the  328  patients  had  CAD
and  26%  had  previous  CABG  surgery  [3].  In  the  UK  TAVI  reg-
istry  48%  of  the  870  patients  who  underwent  TAVI  had  CAD
and  30%  had  previous  cardiac  surgery  [4].  The  percentage
of  patients  who  had  undergone  PCI  in  these  studies  was  not
provided  [2—4].  The  German  TAVI  registry  reported  21%  of
the  697  patients  having  a  prior  CABG,  34%  a  PCI  and  14%
a  balloon  valvuloplasty  [5].  Clinical  outcomes  were  anal-
ysed  only  once  patients  were  undergoing  the  TAVI  procedure
[2—5].In  daily  practice,  however,  coronary  angiography  and
PCI  are  often  performed  a  few  days  or  weeks  before
TAVI,  as  percutaneous  access  to  the  coronary  artery  tree
may  be  compromised  after  TAVI  and  revascularization  of
[
1875-2136/$ — see front matter © 2013 Published by Elsevier Masson SAS
http://dx.doi.org/10.1016/j.acvd.2013.04.002igniﬁcant  CAD  may  improve  outcome  in  the  setting  of  TAVI.
oreover,  patients  with  depressed  left  ventricular  ejection
raction  and  severe  aortic  stenosis  may  undergo  percuta-
eous  balloon  valvuloplasty  as  a  bridge  to  TAVI.  Stroke,
rterial  access  mishap,  bleeding  and  acute  kidney  injury
ay  complicate  pre-TAVI  percutaneous  procedures  in  elderly
atients.  Untoward  events,  including  heart  failure  decom-
ensation  or  sudden  death,  can  also  occur  while  awaiting
 TAVI.  Such  complications  have  to  be  taken  into  consider-
tion  when  comparing  clinical  outcomes  in  TAVI  and  surgical
ohorts.  Present  registries  have  focused  on  outcomes  post-
AVI  without  tallying  up  outcomes  of  pre-TAVI  procedures
2].
In  future  controlled  studies  on  TAVI,  when  coronary  revas-
ularization  is  indicated,  the  outcome  following  surgical
ortic  valve  replacement  and  CABG  needs  to  be  compared
ith  that  of  pre-TAVI  and  TAVI  procedures  and  not  exclusively
ith  TAVI  alone.
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